skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Risk reduction with clopidogrel in the management of peripheral arterial disease

(2420) Views  (482) Full article downloads

Authors: Keshav R Nayak, Jeffrey J Cavendish

Published Date August 2007 Volume 2007:3(3) Pages 289 - 297
DOI: http://dx.doi.org/10.2147/VHRM.S

Keshav R Nayak, Jeffrey J Cavendish

Department of Cardiology, Naval Medical Center San Diego, San Diego, CA, USA

Abstract: Peripheral arterial disease (PAD) is a condition typified by decreased arterial blood flow in the non-coronary branches of the aorta as a result of chronic atherosclerosis. Despite the higher prevalence of PAD compared with other cardiovascular entities such as myocardial infarction and stroke, far less import is given to its diagnosis and treatment. In this review, we highlight principal diagnostic and therapeutic considerations in the management of PAD and its complications. We particularly emphasize the role of clopidogrel in the reduction of risks associated with PAD.

Keywords: clopidogrel, antiplatelet therapy, peripheral artery disease








Readers of this article also read:

Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: Comparison with high cardiovascular risk population
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting: approval and efficacy
Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention
Determinants to optimize response to clopidogrel in acute coronary syndrome
Mid-term outcomes of patients with PCI prior to CABG in comparison to patients with primary CABG
The utility of troponin measurement to detect myocardial infarction: review of the current findings
Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility
Corrigendum
Corrigendum
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University